Pneumagen raises £8m for development June 2023 Equity Gap portfolio company PNEUMAGEN raises £8m to accelerate clinical development. Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infections